Molecular profiling of non-genotoxic hepatocarcinogenesis using differential display reverse transcription-polymerase chain reaction (ddRT-PCR).

Abstract:

:The technique of differential display reverse transcription-polymerase chain reaction (ddRT-PCR) has been used to produce unique profiles of up-regulated and down-regulated gene expression in the liver of male Wistar rats following short term exposure to the non-genotoxic hepatocarcinogens, phenobarbital and WY-14,643. Animals were treated for 3 days, whereupon their livers were extracted and snap frozen. mRNA was prepared from the livers and used for ddRT-PCR. Individual bands from the differential displays were extracted and cloned. False positives were eliminated by dotblot screening and true positives then sequenced and identified.

authors

Rockett JC,Esdaile DJ,Gibson GG

doi

10.1007/BF03190966

subject

Has Abstract

pub_date

1997-10-01 00:00:00

pages

329-33

issue

4

eissn

0378-7966

issn

2107-0180

journal_volume

22

pub_type

杂志文章
  • Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.

    abstract::The absorption, disposition, biotransformation and excretion of the nonsteroidal anti-inflammatory drug pirazolac were investigated in 6 volunteers (3 males, 3 females, age 50 greater than years) after intravenous and oral administration of 50 mg 14C-pirazolac as an aqueous solution of the sodium salt. Pirazolac was v...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189696

    authors: Täuber U,Weiss C,Krause W,Acksteiner B,Matthes H

    更新日期:1985-01-01 00:00:00

  • The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood-Brain Barrier in Rats.

    abstract:BACKGROUND AND OBJECTIVE:Sorafenib is an oral, multikinase inhibitor with established single-agent activity in several tumor types. Sorafenib was moderately transported by P-glycoprotein (P-gp) and more efficiently by breast cancer resistance protein. The constitutive androstane receptor (CAR) is a ligand-activated tra...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00639-z

    authors: Karbownik A,Stanisławiak-Rudowicz J,Stachowiak A,Romański M,Grześkowiak E,Szałek E

    更新日期:2020-12-01 00:00:00

  • Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate.

    abstract:BACKGROUND AND OBJECTIVES:Clopidogrel is an antiplatelet and antithrombotic prodrug. It has poor oral bioavailability due to poor dissolution and possible premature degradation in the intestine. Accordingly, the objective of this study was to enhance clopidogrel dissolution rate and to reduce its premature degradation ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-015-0311-4

    authors: Bali DE,Osman MA,El Maghraby GM

    更新日期:2016-12-01 00:00:00

  • Hepatic metabolism of doxorubicin in mice and rats.

    abstract::We have studied the metabolism of doxorubicin in rat and mouse liver, heart and hepatocytes. Doxorubicinol was present in all cases at very low levels and 7-deoxyaglycones were present only in extraphysiological conditions: no aglycones were found either in fresh livers or in hearts of animals treated with the drug, b...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189834

    authors: Vrignaud P,Londos-Gagliardi D,Robert J

    更新日期:1986-04-01 00:00:00

  • Statistical aspects of bioequivalence testing between two medicinal products.

    abstract::A generic drug product (test product) is bioequivalent to an innovator product (reference product) when their bioavailabilities in the same molar dose are similar. Bioavailability is expressed by pharmacokinetic parameters such as the area under plasma concentration-time curve (AUC), the maximum plasma concentration (...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03226406

    authors: Zintzaras E

    更新日期:2005-01-01 00:00:00

  • The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.

    abstract::Following i.v. administration of mono-HR to the beagle, plasma levels of both mono-HR and its glucuronide conjugates fell rapidly, neither being detectable 8 h after injection. Following oral administration of 14C-mono-HR, mono-HR-glucuronide was detected in plasma, confirming the absorption of mono-HR, and low levels...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189428

    authors: Hackett AM,Griffiths LA

    更新日期:1979-01-01 00:00:00

  • The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.

    abstract:OBJECTIVE:By using a population pharmacokinetic analysis method, we predicted the efficacy of Ceftriaxone (CTRX) based on the pharmacokinetics of CTRX in Japanese adults and the sensitivity of infective organisms to CTRX in 2004. In addition, we clarified the difference in efficacy between once-a-day administration and...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03191159

    authors: Iida S,Kinoshita H,Kawanishi T,Hayashi M

    更新日期:2009-04-01 00:00:00

  • Phenobarbital-digitoxin interaction in the guinea pig liver.

    abstract::The influence of phenobarbital pretreatment on liver concentration of digitoxin and its metabolites was studied in guinea-pigs after i.p. administration of the cardiac glycoside. During the first hour an increase in liver uptake was observed in pretreated animals. The differences detected in the hepatic subcellular di...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189562

    authors: Carvalhas ML,Figueira MA,Maya MR

    更新日期:1982-01-01 00:00:00

  • Effect of metal salts on UDPglucuronosyltransferase activity of various aglycones in rat liver microsomes in vitro.

    abstract::The effects of aluminium, manganese, ferrous and ferric iron, cobalt, nickel, copper, zinc, cadmium, barium, mercury and lead ions on the rat hepatic UDPglucuronosyltransferase activity with regard to 4-methylumbelliferone, 4-nitrophenol, bilirubin, and 2-aminophenol were investigated in vitro. Conjugation of bilirubi...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189441

    authors: Aitio A,Ahotupa M,Parkki MG

    更新日期:1980-01-01 00:00:00

  • Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.

    abstract::Hepatic transporters and metabolic enzymes affect drug pharmacokinetics. Limited information exists on the alteration in mRNA levels of hepatic transporters and metabolic enzymes with aging. We examined the effects of aging on the mRNA levels of representative hepatic drug transporters and metabolic enzymes by analyzi...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-014-0208-7

    authors: Kawase A,Ito A,Yamada A,Iwaki M

    更新日期:2015-06-01 00:00:00

  • Estimation of hepatic distributional volumes using non-labeled reference markers.

    abstract::Hepatic distributional volumes were investigated in the in situ perfused rat liver. Perfusion experiments were conducted using Krebs bicarbonate buffer delivered via the portal vein in single-pass mode at a total flow rate of 15 mL/min. A bolus dose of normal erythrocytes (RBC, vascular marker) and Evans blue (EB, ext...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190469

    authors: Karabey Y,Sahin S

    更新日期:2006-10-01 00:00:00

  • Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release.

    abstract::This paper deals with press-coated modified release tablets in which the drug dose is situated in the core or is divided between the core and the coat. The coat contains polymer (sodium alginate or hydroxypropylmethyl cellulose, HPMC) to control drug release. The main objective was to investigate how the pharmacokinet...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF03189338

    authors: Halsas M,Ervasti P,Veski P,Jürjenson H,Marvola M

    更新日期:1998-04-01 00:00:00

  • Deuterium isotope effects on caffeine metabolism.

    abstract::The aim of this work was to study the influence of labelling on caffeine metabolism according to the incubation mode. It has been observed that labelling induces an isotopic effect on metabolisation speed: apparent half-lives are systematically increased. Moreover, isotopic effects are in agreement with those previous...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189795

    authors: Benchekroun Y,Dautraix S,Desage M,Brazier JL

    更新日期:1997-04-01 00:00:00

  • Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice.

    abstract::Sertraline potently inhibits cytochrome P450 2B6 (CYP2B6) in vitro. Bupropion is commonly co-prescribed with sertraline and is exclusively metabolized by CYP2B6 to its major active metabolite hydroxybupropion. Putatively the co-administration of bupropion and sertraline could lead to a significant pharmacokinetic drug...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-011-0065-6

    authors: Molnari JC,Hassan HE,Myers AL

    更新日期:2012-03-01 00:00:00

  • Pharmacokinetic and pharmacodynamic data and models in clinical trials.

    abstract::There is current emphasis for extended integration of pharmacokinetics (PK) and pharmacodynamics (PD) into all phases of new drug development, including large-scale clinical trials. In this paper, we focus on study design and data analysis issues for the investigation of pharmacokinetic/pharmacodynamic and blood level...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/BF03220009

    authors: Steimer JL,Ebelin ME,Van Bree J

    更新日期:1993-01-01 00:00:00

  • Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis.

    abstract::We studied the hepatic handling of bromosulfophthalein in healthy rabbits with hepatic coccidiosis 28 days after an experimental infection with sporulated oocysts of Eimeria stiedai, an experimental model of liver disease histopathologically resembling primary biliary cirrhosis in man. A pharmacokinetic study of the r...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190121

    authors: Esteller A,Torres MD,Gomez-Bautista M,Mariño EL,Fernandez-Lastra C,Jimenez R

    更新日期:1990-01-01 00:00:00

  • Preclinical evaluation of drug in adhesive type ondansetron loaded transdermal therapeutic systems.

    abstract::The in vivo assessment of percutaneous absorption of molecules is a very important step in the evaluation of any transdermal drug delivery system and a key goal in the design and optimization of transdermal dosage forms lies in understanding the factors that determine a good in vivo performance. The objective of the p...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-011-0053-x

    authors: Swain K,Pattnaik S,Yeasmin N,Mallick S

    更新日期:2011-12-01 00:00:00

  • Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker.

    abstract::The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50% rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (Cl) decreased by approximately 2/3 o...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190205

    authors: Kaka JS,al-Khamis K,Tanira MO

    更新日期:1990-07-01 00:00:00

  • Inducibility of rat brain drug-metabolizing enzymes.

    abstract::Cytochrome P450 from rat brain mitochondrial and microsomal fractions was found to be inducible by 3-methylcholanthrene, both in quantity of enzyme and in activity towards 7-ethoxyresorufin, which is a model substrate for the cytochrome P450 isoform specifically induced by 3-methylcholanthrene. Conversely, a phenobarb...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189910

    authors: Ghersi-Egea JF,Walther B,Perrin R,Minn A,Siest G

    更新日期:1987-10-01 00:00:00

  • Chlormezanone plasma and blood levels in patients after single and repeated oral doses and after suicidal drug overdose.

    abstract::Chlormezanone plasma concentrations were determined in 5 volunteers (group 1) after a single oral dose of 200 mg of chlormezanone with high performance liquid chromatography. A plasma elimination half-life of 23 +/- 2.3 h was calculated. The mean peak chlormezanone plasma level was 1.86 +/- 0.2 micrograms/ml, 1 h afte...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189873

    authors: Köppel C,Kristinsson J,Wagemann A,Tenczer J,Martens F

    更新日期:1991-01-01 00:00:00

  • Bioequivalence studies: biometrical concepts of alternative designs and pooled analysis.

    abstract::A bioequivalence study compares the bioavailability between a test and a reference drug product in terms of the rate and extent of drug absorption. Area under the plasma concentration-time curve (AUC) and maximum plasma concentration (Cmax) are the pharmacokinetic parameters that serve as characteristics for the asses...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190024

    authors: Zintzaras E,Bouka P

    更新日期:1999-07-01 00:00:00

  • Prediction of Half-Life Extension of Peptides via Serum Albumin Binding: Current Challenges.

    abstract::The development of peptide therapeutics has increased enormously in recent decades. Many of the peptide drugs and antibody fragments that lack Fc backbone have a short half-life in circulation. In general, the half-life supports the design of the dosing regimen and frequency of administration, which are key aspects in...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00664-y

    authors: Hijazi Y

    更新日期:2021-01-01 00:00:00

  • Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form.

    abstract::Microcomputers have been used in pharmacokinetics for several years, but their use in the area of formulation is a new application. By using appropriate data on the drug, the dosage form required and its mechanism of absorption and clearance, microcomputers can systematize and speed-up formulation, simplify manufactur...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/BF03189611

    authors: Aiache JM,Turlier M,Tanguy A

    更新日期:1984-04-01 00:00:00

  • Pharmacokinetics of chlordesmethyldiazepam after single-dose oral administration in humans.

    abstract::The pharmacokinetics of chlordemethyldiazepam--a pharmacologically very active new 1,4-benzodiazepine derivative--in healthy subjects after administration of a single oral dose of 2 mg, was studied. Peak concentrations were reached in 1.2 +/- 0.2 hours. Plasma levels declined with a biphasic pattern, and the eliminati...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189844

    authors: Bareggi SR,Pirola R,Leva S,Zecca L

    更新日期:1986-07-01 00:00:00

  • The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.

    abstract::Danirixin (GSK1325756) is a small, high-affinity, selective and reversible CXCR2 antagonist in development for treatment of chronic obstructive pulmonary disease. The objective of the study was to evaluate the relative bioavailability, including the inter-subject variability, of a conventional immediate-release (IR) f...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s13318-014-0179-8

    authors: Miller BE,Smart K,Mistry S,Ambery CL,Bloomer JC,Connolly P,Sanderson D,Shreeves T,Smith R,Lazaar AL

    更新日期:2014-09-01 00:00:00

  • Method of variability optimization in pharmacokinetic data analysis.

    abstract::For many drugs administered per os, high variability in the concentration-time (C-T) values from first sampling to the phase of distribution may cause difficulty in pharmacokinetic analysis. Therefore, the aim of this study was to propose a method of transformation of C-T data, which would allow significantly reducing...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-013-0145-x

    authors: Grabowski T,Jaroszewski JJ,Piotrowski W,Sasinowska-Motyl M

    更新日期:2014-06-01 00:00:00

  • Comparative pharmacokinetics of salicylate in camels, sheep and goats.

    abstract::This study compared some pharmacokinetic parameters of DL-lysine-acetyl salicylate administered intravenously (i.v.) and intramuscularly (i.m.) at a dose of 20 mg/kg in camels, sheep and goats. The data was analyzed using a non-compartmental model. In camels, sheep and goats given the drug i.v., the t1/2 values were 4...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190500

    authors: Ali BH

    更新日期:2003-04-01 00:00:00

  • Stereoselective disposition of RS-tocainide in man.

    abstract::The disposition of RS-tocainide in three healthy volunteers has been studied after oral administration of a pseudoracemic mixture containing S(+) [3H] tocainide as a radioactive tracer together with a therapeutic dose of the racemate. Analytical methods based on HPLC have been developed to measure S(+) and R(-) tocain...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189644

    authors: Hoffmann KJ,Renberg L,Bäärnhielm C

    更新日期:1984-07-01 00:00:00

  • Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.

    abstract::Metoprolol Oros tablets were designed to deliver their drug content as a constant rate over a period of time longer than that currently recorded with slow-release dosage forms. The bioavailability of 7/95, 14/190 and 21/285 Oros tablets was compared to that of either 100 mg conventional or 200 mg slow-release Lopresor...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188865

    authors: Richard J,Cardot JM,Godbillon J

    更新日期:1994-10-01 00:00:00

  • Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.

    abstract::The pharmacokinetic profile of triflusal (2-acetoxy-4-trifluoromethyl benzoic acid) and its main metabolite HTB (2-hydroxy-4-trifluoromethyl benzoic acid) has been studied in 8 healthy subjects (4 males and 4 females), after a single oral dose of 900 mg of triflusal. Plasma concentrations were determined by a sensitiv...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189971

    authors: Ramis J,Mis R,Forn J,Torrent J,Gorina E,Jané F

    更新日期:1991-10-01 00:00:00